Pulsion Medical Systems   Report issue

For profit Phase 2
Founded: Feldkirchen Germany (1990)
Status: Left NME R&D (2018)

Organization Overview

First Clinical Trial
2008
NCT00624650
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Lung Injury (Phase 2)

Lung Injury (Phase 2)

Respiratory Distress Syndrome (Phase 2)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 6